FDA Drug information
Ambrisentan
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Ambrisentan AMBRISENTAN 10 mg/1 Apotex Corp.
- Ambrisentan AMBRISENTAN 10 mg/1 Aurobindo Pharma Limited
- Ambrisentan AMBRISENTAN 10 mg/1 Cipla USA Inc.
- Ambrisentan AMBRISENTAN 10 mg/1 Mylan Pharmaceuticals Inc.
- Ambrisentan AMBRISENTAN 10 mg/1 Quallent Pharmaceuticals Health LLC
- Ambrisentan AMBRISENTAN 10 mg/1 Sun Pharmaceutical Industries, Inc.
- Ambrisentan AMBRISENTAN 10 mg/1 Zydus Lifesciences Limited
- Ambrisentan AMBRISENTAN 10 mg/1 Zydus Pharmaceuticals USA Inc.
- Ambrisentan AMBRISENTAN 5 mg/1 Apotex Corp.
- Ambrisentan AMBRISENTAN 5 mg/1 Aurobindo Pharma Limited
- Ambrisentan AMBRISENTAN 5 mg/1 Cipla USA Inc.
- Ambrisentan AMBRISENTAN 5 mg/1 Mylan Pharmaceuticals Inc.
- Ambrisentan AMBRISENTAN 5 mg/1 Quallent Pharmaceuticals Health LLC
- Ambrisentan AMBRISENTAN 5 mg/1 Sun Pharmaceutical Industries, Inc.
- Ambrisentan AMBRISENTAN 5 mg/1 Zydus Lifesciences Limited
- Ambrisentan AMBRISENTAN 5 mg/1 Zydus Pharmaceuticals USA Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.